Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology.
about
Aldosterone synthase inhibition in humansAldosterone modulates steroid receptor binding to the endothelin-1 gene (edn1)Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptorsBenefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to comNew drug therapies interfering with the renin-angiotensin-aldosterone system for resistant hypertension.Mineralocorticoid receptors in vascular disease: connecting molecular pathways to clinical implications.Sensitization of slow pressor angiotensin II (Ang II)-initiated hypertension: induction of sensitization by prior Ang II treatment.The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain.PVN adenovirus-siRNA injections silencing either NOX2 or NOX4 attenuate aldosterone/NaCl-induced hypertension in mice.Mineralocorticoid receptors in vascular function and disease.Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease.Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation.Aldosterone synthase inhibition in hypertension.Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.The role of Na+-H+ exchanger isoform 1 in aldosterone-induced glomerulosclerosis in vivo.Study of aldosterone synthase inhibition as an add-on therapy in resistant hypertension.Adrenal corticosteroid effects in the central nervous system on long-term control of blood pressure.Role of smooth muscle cell mineralocorticoid receptor in vascular tone.Decrease of nitric oxide and increase in diastolic blood pressure are two events that affect renal function in dogs with pituitary dependent hyperadrenocorticism.
P2860
Q27016157-DDA4C29E-2536-45F6-B5CD-14A7EF348C5BQ28571217-F0309B69-47A0-460A-97A6-F23834B5D059Q30528005-DDE7D751-DBE7-431B-AE4A-7ADD81151974Q33960590-C7859A00-7DB9-41A1-B7E5-7E5850AC5873Q34384580-BBBB8DED-9EF3-472D-AEEA-E8DFFEAC7D30Q34684861-094CF576-0F65-4968-AD64-F4E2D1C7F820Q35812259-60E219CC-E5FC-47E1-9883-957D6135E1DDQ35883217-8A3F19F2-D52F-4965-9294-6B3D4C158D46Q35964957-36262FC0-768F-4909-9E50-15F52773D4D1Q37896953-DA3DF20B-CD4C-4CB0-94E4-3E6BF55559E7Q37984036-A6EE862F-ED3C-4ADB-9C2C-BD2614D8D5AFQ38103479-2B049B5C-CB18-4E22-819A-84D7957901D4Q38109661-5B4BA18F-D72A-4176-84B0-3854B82A6CE6Q38126805-13BD7A06-54D5-4105-BE25-BCC4233B023CQ43143859-6165D352-EF2E-4469-8D1D-A580E3626464Q43265101-30B585A0-BF2E-45A9-8855-7C8742276C46Q44119714-BB464F07-8B3D-4E32-8B0B-43654FA52273Q47117893-FB6D1572-EE05-4ACC-AB95-AF02DFAC83F9Q54319088-48467E42-5D88-4CF2-97CE-A0B525758B6AQ55279281-1341DB60-E11B-4E1A-8C9A-117CFB1F7048
P2860
Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology.
@en
Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology.
@nl
type
label
Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology.
@en
Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology.
@nl
prefLabel
Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology.
@en
Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology.
@nl
P1476
Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology
@en
P2093
John W Funder
P356
10.1016/J.MCE.2008.10.029
P577
2008-10-31T00:00:00Z